Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Interferon-β-1a-induced psychosis in a patient with multiple sclerosis.
Efficacy of statins in combination with interferon therapy in multiple sclerosis: A meta-analysis.
The role of cerebellar abnormalities in neuromyelitis optica - a comparison with multiple sclerosis and healthy controls.
Managing psychological stress in the multiple sclerosis medical visit: Patient perspectives and unmet needs.
Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis.
Cerebral Circulation Time is Prolonged and Not Correlated with EDSS in Multiple Sclerosis Patients: A Study Using Digital Subtracted Angiography.
Aspirin Promotes Oligodendroglial Differentiation Through Inhibition of Wnt Signaling Pathway.
Central Autonomic Dysfunction Delays Recovery of Fingolimod Induced Heart Rate Slowing.
Gas6 enhances axonal ensheathment by MBP+ membranous processes in human DRG/OL promyelinating co-cultures.
Clinical trials in multiple sclerosis.
Genomic Binding Sites and Biological Effects of the Vitamin D: VDR Complex in Multiple Sclerosis.
Redefining Self: Patients' Decision Making About Treatment for Multiple Sclerosis.
The role of invariant NKT cells in organ-specific autoimmunity.
Development of a nanomaterial bio-screening platform for neurological applications.
Aquaporin and brain diseases.
Substance Name: Simvastatin
Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis: a pilot study.
Moving to fingolimod from natalizumab in multiple sclerosis-reply.
MicroRNA-145 as one negative regulator of astrogliosis.
The role of transcriptional control in multiple system atrophy.
Aggregation Kinetics for IgG1-Based Monoclonal Antibody Therapeutics.
POLG mutations associated with remitting/relapsing neurological events.
[Clinical epidemiology of multiple sclerosis in Moscow. Discriptive epidemiology in population of one region of Moscow.]
Eculizumab, Neuromyelitis Optica, and Tuberculosis: We Live An Era of Challenging Combinations.
Costs of Illness of Multiple Sclerosis In Sweden - A Population-Based Register Study.
Pages
« first
‹ previous
…
418
419
420
421
422
423
424
425
426
…
next ›
last »